Ilaris, Injektionslösung

7680661910011 CH-66191 Injektionslösung

Associated product:

ILARIS sol inj 150 mg/ml flac 1 ml
Ilaris, Injektionslösung
Ilaris, Injektionslösung
Ilaris, Injektionslösung
1 / 3
google

Article details

Package size
1
Selling units
1
Measure
Durchstechflasche(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
08/10/2021
Patient information leaflet
Français
08/10/2021
Patient information leaflet
Italien
08/10/2021
Summary of Product Characteristics
Allemand
08/10/2021
Summary of Product Characteristics
Français
08/10/2021
Summary of Product Characteristics
Italien
08/10/2021

Detailed composition

Substance Quantity Type Category
(N/A)
150.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK

Reimbursement information

Public price
CHF 10954.95
Specialties list
Yes
Generic
No

Reimbursement limitation

SL addition date: 01/12/2017

Authorization holder

Novartis Pharma Schweiz AG

6343 Risch

Authorization information

Swissmedic authorization number
66191
Drug name
Ilaris, Injektionslösung
Galenic form
LSINJ
ATC Code
L04AC08
Authorization status
Z
Dispensing category
A
First authorization
15/05/2017
Authorization expiration date
31/12/9999
IT Number
07.15.0.
Domain
Human medicine
Field of application
Cryopyrin-assoziierte Periodische Syndrome (CAPS) wie des Muckle-Wells-Syndroms (MWS), des familiären autoinflammatorischen Kälte-Syndroms (FACS) / der familiären Kälteurtikaria (FCU) und der multisystemischen entzündlichen Erkrankung mit Beginn im Neugeborenenalter (NOMID)/des chronischen infantilen neuro-dermo-artikulären Syndroms (CINCA). Tumornekrosefaktor-Rezeptor-assoziiertes periodisches Syndrom (TRAPS). Hyperimmunglobulin-D-Syndrom (HIDS) / Mevalonatkinasedefizienz (MKD). Familiäres Mittelmeerfieber (FMF). Systemische juvenile idiopathische Arthritis (SJIA). Adultes Still-Syndrom.

Package details

Description (FR)
ILARIS sol inj 150 mg/ml flac 1 ml
Description (DE)
ILARIS Inj Lös 150 mg/ml Durchstf 1 ml
Market launch
15/05/2017
Narcotic (BTM)
No